Drug profile · INN
cefonicid sodium
MONOCID
cefonicid sodium (MONOCID) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefonicid sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefonicid sodium (MONOCID) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefonicid sodium?
cefonicid sodium (MONOCID) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefonicid sodium?
MONOCID is a marketed brand name for cefonicid sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefonicid sodium?
cefonicid sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.